The global market for AI In Vitro Diagnostic was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global market for in vitro diagnostics (IVD) was growing steadily and was expected to continue its growth in the coming years.

Market Overview: The in vitro diagnostics market involves medical devices, instruments, and reagents used for diagnostic testing of samples such as blood, urine, tissue, and other bodily fluids. AI in vitro diagnostics refers to the integration of artificial intelligence and machine learning technologies into these diagnostic tools and processes.

Growth Drivers: The market for AI in vitro diagnostics has been driven by factors such as increasing demand for personalized medicine, rising prevalence of chronic and infectious diseases, technological advancements in diagnostics, and the need for efficient and accurate diagnostic solutions.

Application Areas: AI has found applications in various areas of in vitro diagnostics, including clinical chemistry, immunoassays, microbiology, hematology, genetic testing, and molecular diagnostics. AI algorithms can aid in data analysis, interpretation, and decision-making, improving the accuracy and efficiency of diagnostic procedures.

Report Scope

This report aims to provide a comprehensive presentation of the global market for AI In Vitro Diagnostic, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI In Vitro Diagnostic by region & country, by Type, and by Application.

The AI In Vitro Diagnostic market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI In Vitro Diagnostic.

Market Segmentation

Scope of AI In Vitro Diagnostic - Market Report

Report Metric	Details
Report Name	AI In Vitro Diagnostic - Market
Segment by Type:	Next-Generation Sequencing Technology PCR Technology Chemistry and IA Technology Pathology Technology
Segment by Application	Cancer Diagnostics Infectious Disease Testing Metabolic Testing Cardiac Testing Diabetes Testing
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Renalytix, Seegene, Sysmex, PathAI, Prognos, Qiagen, CloudMedX Health, Deepcell, Digital Diagnostics, EKF Diagnostics Holdings, Freenome, GE Healthcare, Glooko, Adaptive Biotechnologies, Aidoc, Anumana, ARUP Laboratories, K Health, Lunit
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of AI In Vitro Diagnostic manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of AI In Vitro Diagnostic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of AI In Vitro Diagnostic in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the AI In Vitro Diagnostic - Market report?

Ans: The main players in the AI In Vitro Diagnostic - Market are Renalytix, Seegene, Sysmex, PathAI, Prognos, Qiagen, CloudMedX Health, Deepcell, Digital Diagnostics, EKF Diagnostics Holdings, Freenome, GE Healthcare, Glooko, Adaptive Biotechnologies, Aidoc, Anumana, ARUP Laboratories, K Health, Lunit

What are the Application segmentation covered in the AI In Vitro Diagnostic - Market report?

Ans: The Applications covered in the AI In Vitro Diagnostic - Market report are Cancer Diagnostics, Infectious Disease Testing, Metabolic Testing, Cardiac Testing, Diabetes Testing

What are the Type segmentation covered in the AI In Vitro Diagnostic - Market report?

Ans: The Types covered in the AI In Vitro Diagnostic - Market report are Next-Generation Sequencing Technology, PCR Technology, Chemistry and IA Technology, Pathology Technology

1 Market Overview

1.1 AI In Vitro Diagnostic Product Introduction

1.2 Global AI In Vitro Diagnostic Market Size Forecast

1.3 AI In Vitro Diagnostic Market Trends & Drivers

1.3.1 AI In Vitro Diagnostic Industry Trends

1.3.2 AI In Vitro Diagnostic Market Drivers & Opportunity

1.3.3 AI In Vitro Diagnostic Market Challenges

1.3.4 AI In Vitro Diagnostic Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global AI In Vitro Diagnostic Players Revenue Ranking (2023)

2.2 Global AI In Vitro Diagnostic Revenue by Company (2019-2024)

2.3 Key Companies AI In Vitro Diagnostic Manufacturing Base Distribution and Headquarters

2.4 Key Companies AI In Vitro Diagnostic Product Offered

2.5 Key Companies Time to Begin Mass Production of AI In Vitro Diagnostic

2.6 AI In Vitro Diagnostic Market Competitive Analysis

2.6.1 AI In Vitro Diagnostic Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by AI In Vitro Diagnostic Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Vitro Diagnostic as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Next-Generation Sequencing Technology

3.1.2 PCR Technology

3.1.3 Chemistry and IA Technology

3.1.4 Pathology Technology

3.2 Global AI In Vitro Diagnostic Sales Value by Type

3.2.1 Global AI In Vitro Diagnostic Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global AI In Vitro Diagnostic Sales Value, by Type (2019-2030)

3.2.3 Global AI In Vitro Diagnostic Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cancer Diagnostics

4.1.2 Infectious Disease Testing

4.1.3 Metabolic Testing

4.1.4 Cardiac Testing

4.1.5 Diabetes Testing

4.2 Global AI In Vitro Diagnostic Sales Value by Application

4.2.1 Global AI In Vitro Diagnostic Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global AI In Vitro Diagnostic Sales Value, by Application (2019-2030)

4.2.3 Global AI In Vitro Diagnostic Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global AI In Vitro Diagnostic Sales Value by Region

5.1.1 Global AI In Vitro Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global AI In Vitro Diagnostic Sales Value by Region (2019-2024)

5.1.3 Global AI In Vitro Diagnostic Sales Value by Region (2025-2030)

5.1.4 Global AI In Vitro Diagnostic Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America AI In Vitro Diagnostic Sales Value, 2019-2030

5.2.2 North America AI In Vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe AI In Vitro Diagnostic Sales Value, 2019-2030

5.3.2 Europe AI In Vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific AI In Vitro Diagnostic Sales Value, 2019-2030

5.4.2 Asia Pacific AI In Vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America AI In Vitro Diagnostic Sales Value, 2019-2030

5.5.2 South America AI In Vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa AI In Vitro Diagnostic Sales Value, 2019-2030

5.6.2 Middle East & Africa AI In Vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions AI In Vitro Diagnostic Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions AI In Vitro Diagnostic Sales Value

6.3 United States

6.3.1 United States AI In Vitro Diagnostic Sales Value, 2019-2030

6.3.2 United States AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.3.3 United States AI In Vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe AI In Vitro Diagnostic Sales Value, 2019-2030

6.4.2 Europe AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe AI In Vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China AI In Vitro Diagnostic Sales Value, 2019-2030

6.5.2 China AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.5.3 China AI In Vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan AI In Vitro Diagnostic Sales Value, 2019-2030

6.6.2 Japan AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan AI In Vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea AI In Vitro Diagnostic Sales Value, 2019-2030

6.7.2 South Korea AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea AI In Vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia AI In Vitro Diagnostic Sales Value, 2019-2030

6.8.2 Southeast Asia AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia AI In Vitro Diagnostic Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India AI In Vitro Diagnostic Sales Value, 2019-2030

6.9.2 India AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

6.9.3 India AI In Vitro Diagnostic Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Renalytix

7.1.1 Renalytix Profile

7.1.2 Renalytix Main Business

7.1.3 Renalytix AI In Vitro Diagnostic Products, Services and Solutions

7.1.4 Renalytix AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.1.5 Renalytix Recent Developments

7.2 Seegene

7.2.1 Seegene Profile

7.2.2 Seegene Main Business

7.2.3 Seegene AI In Vitro Diagnostic Products, Services and Solutions

7.2.4 Seegene AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.2.5 Seegene Recent Developments

7.3 Sysmex

7.3.1 Sysmex Profile

7.3.2 Sysmex Main Business

7.3.3 Sysmex AI In Vitro Diagnostic Products, Services and Solutions

7.3.4 Sysmex AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.3.5 PathAI Recent Developments

7.4 PathAI

7.4.1 PathAI Profile

7.4.2 PathAI Main Business

7.4.3 PathAI AI In Vitro Diagnostic Products, Services and Solutions

7.4.4 PathAI AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.4.5 PathAI Recent Developments

7.5 Prognos

7.5.1 Prognos Profile

7.5.2 Prognos Main Business

7.5.3 Prognos AI In Vitro Diagnostic Products, Services and Solutions

7.5.4 Prognos AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.5.5 Prognos Recent Developments

7.6 Qiagen

7.6.1 Qiagen Profile

7.6.2 Qiagen Main Business

7.6.3 Qiagen AI In Vitro Diagnostic Products, Services and Solutions

7.6.4 Qiagen AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.6.5 Qiagen Recent Developments

7.7 CloudMedX Health

7.7.1 CloudMedX Health Profile

7.7.2 CloudMedX Health Main Business

7.7.3 CloudMedX Health AI In Vitro Diagnostic Products, Services and Solutions

7.7.4 CloudMedX Health AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.7.5 CloudMedX Health Recent Developments

7.8 Deepcell

7.8.1 Deepcell Profile

7.8.2 Deepcell Main Business

7.8.3 Deepcell AI In Vitro Diagnostic Products, Services and Solutions

7.8.4 Deepcell AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.8.5 Deepcell Recent Developments

7.9 Digital Diagnostics

7.9.1 Digital Diagnostics Profile

7.9.2 Digital Diagnostics Main Business

7.9.3 Digital Diagnostics AI In Vitro Diagnostic Products, Services and Solutions

7.9.4 Digital Diagnostics AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.9.5 Digital Diagnostics Recent Developments

7.10 EKF Diagnostics Holdings

7.10.1 EKF Diagnostics Holdings Profile

7.10.2 EKF Diagnostics Holdings Main Business

7.10.3 EKF Diagnostics Holdings AI In Vitro Diagnostic Products, Services and Solutions

7.10.4 EKF Diagnostics Holdings AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.10.5 EKF Diagnostics Holdings Recent Developments

7.11 Freenome

7.11.1 Freenome Profile

7.11.2 Freenome Main Business

7.11.3 Freenome AI In Vitro Diagnostic Products, Services and Solutions

7.11.4 Freenome AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.11.5 Freenome Recent Developments

7.12 GE Healthcare

7.12.1 GE Healthcare Profile

7.12.2 GE Healthcare Main Business

7.12.3 GE Healthcare AI In Vitro Diagnostic Products, Services and Solutions

7.12.4 GE Healthcare AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.12.5 GE Healthcare Recent Developments

7.13 Glooko

7.13.1 Glooko Profile

7.13.2 Glooko Main Business

7.13.3 Glooko AI In Vitro Diagnostic Products, Services and Solutions

7.13.4 Glooko AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.13.5 Glooko Recent Developments

7.14 Adaptive Biotechnologies

7.14.1 Adaptive Biotechnologies Profile

7.14.2 Adaptive Biotechnologies Main Business

7.14.3 Adaptive Biotechnologies AI In Vitro Diagnostic Products, Services and Solutions

7.14.4 Adaptive Biotechnologies AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.14.5 Adaptive Biotechnologies Recent Developments

7.15 Aidoc

7.15.1 Aidoc Profile

7.15.2 Aidoc Main Business

7.15.3 Aidoc AI In Vitro Diagnostic Products, Services and Solutions

7.15.4 Aidoc AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.15.5 Aidoc Recent Developments

7.16 Anumana

7.16.1 Anumana Profile

7.16.2 Anumana Main Business

7.16.3 Anumana AI In Vitro Diagnostic Products, Services and Solutions

7.16.4 Anumana AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.16.5 Anumana Recent Developments

7.17 ARUP Laboratories

7.17.1 ARUP Laboratories Profile

7.17.2 ARUP Laboratories Main Business

7.17.3 ARUP Laboratories AI In Vitro Diagnostic Products, Services and Solutions

7.17.4 ARUP Laboratories AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.17.5 ARUP Laboratories Recent Developments

7.18 K Health

7.18.1 K Health Profile

7.18.2 K Health Main Business

7.18.3 K Health AI In Vitro Diagnostic Products, Services and Solutions

7.18.4 K Health AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.18.5 K Health Recent Developments

7.19 Lunit

7.19.1 Lunit Profile

7.19.2 Lunit Main Business

7.19.3 Lunit AI In Vitro Diagnostic Products, Services and Solutions

7.19.4 Lunit AI In Vitro Diagnostic Revenue (US$ Million) & (2019-2024)

7.19.5 Lunit Recent Developments

8 Industry Chain Analysis

8.1 AI In Vitro Diagnostic Industrial Chain

8.2 AI In Vitro Diagnostic Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 AI In Vitro Diagnostic Sales Model

8.5.2 Sales Channel

8.5.3 AI In Vitro Diagnostic Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

EKF Diagnostics Holdings

Freenome

GE Healthcare

Glooko

Adaptive Biotechnologies

List of Tables

Table 1. AI In Vitro Diagnostic Market Trends

Table 2. AI In Vitro Diagnostic Market Drivers & Opportunity

Table 3. AI In Vitro Diagnostic Market Challenges

Table 4. AI In Vitro Diagnostic Market Restraints

Table 5. Global AI In Vitro Diagnostic Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global AI In Vitro Diagnostic Revenue Market Share by Company (2019-2024)

Table 7. Key Companies AI In Vitro Diagnostic Manufacturing Base Distribution and Headquarters

Table 8. Key Companies AI In Vitro Diagnostic Product Type

Table 9. Key Companies Time to Begin Mass Production of AI In Vitro Diagnostic

Table 10. Global AI In Vitro Diagnostic Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Vitro Diagnostic as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global AI In Vitro Diagnostic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global AI In Vitro Diagnostic Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global AI In Vitro Diagnostic Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global AI In Vitro Diagnostic Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global AI In Vitro Diagnostic Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global AI In Vitro Diagnostic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global AI In Vitro Diagnostic Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global AI In Vitro Diagnostic Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global AI In Vitro Diagnostic Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global AI In Vitro Diagnostic Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global AI In Vitro Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global AI In Vitro Diagnostic Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global AI In Vitro Diagnostic Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global AI In Vitro Diagnostic Sales Value by Region (2019-2024) & (%)

Table 27. Global AI In Vitro Diagnostic Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions AI In Vitro Diagnostic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions AI In Vitro Diagnostic Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions AI In Vitro Diagnostic Sales Value, (2025-2030) & (US$ Million)

Table 31. Renalytix Basic Information List

Table 32. Renalytix Description and Business Overview

Table 33. Renalytix AI In Vitro Diagnostic Products, Services and Solutions

Table 34. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Renalytix (2019-2024)

Table 35. Renalytix Recent Developments

Table 36. Seegene Basic Information List

Table 37. Seegene Description and Business Overview

Table 38. Seegene AI In Vitro Diagnostic Products, Services and Solutions

Table 39. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Seegene (2019-2024)

Table 40. Seegene Recent Developments

Table 41. Sysmex Basic Information List

Table 42. Sysmex Description and Business Overview

Table 43. Sysmex AI In Vitro Diagnostic Products, Services and Solutions

Table 44. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Sysmex (2019-2024)

Table 45. Sysmex Recent Developments

Table 46. PathAI Basic Information List

Table 47. PathAI Description and Business Overview

Table 48. PathAI AI In Vitro Diagnostic Products, Services and Solutions

Table 49. Revenue (US$ Million) in AI In Vitro Diagnostic Business of PathAI (2019-2024)

Table 50. PathAI Recent Developments

Table 51. Prognos Basic Information List

Table 52. Prognos Description and Business Overview

Table 53. Prognos AI In Vitro Diagnostic Products, Services and Solutions

Table 54. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Prognos (2019-2024)

Table 55. Prognos Recent Developments

Table 56. Qiagen Basic Information List

Table 57. Qiagen Description and Business Overview

Table 58. Qiagen AI In Vitro Diagnostic Products, Services and Solutions

Table 59. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Qiagen (2019-2024)

Table 60. Qiagen Recent Developments

Table 61. CloudMedX Health Basic Information List

Table 62. CloudMedX Health Description and Business Overview

Table 63. CloudMedX Health AI In Vitro Diagnostic Products, Services and Solutions

Table 64. Revenue (US$ Million) in AI In Vitro Diagnostic Business of CloudMedX Health (2019-2024)

Table 65. CloudMedX Health Recent Developments

Table 66. Deepcell Basic Information List

Table 67. Deepcell Description and Business Overview

Table 68. Deepcell AI In Vitro Diagnostic Products, Services and Solutions

Table 69. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Deepcell (2019-2024)

Table 70. Deepcell Recent Developments

Table 71. Digital Diagnostics Basic Information List

Table 72. Digital Diagnostics Description and Business Overview

Table 73. Digital Diagnostics AI In Vitro Diagnostic Products, Services and Solutions

Table 74. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Digital Diagnostics (2019-2024)

Table 75. Digital Diagnostics Recent Developments

Table 76. EKF Diagnostics Holdings Basic Information List

Table 77. EKF Diagnostics Holdings Description and Business Overview

Table 78. EKF Diagnostics Holdings AI In Vitro Diagnostic Products, Services and Solutions

Table 79. Revenue (US$ Million) in AI In Vitro Diagnostic Business of EKF Diagnostics Holdings (2019-2024)

Table 80. EKF Diagnostics Holdings Recent Developments

Table 81. Freenome Basic Information List

Table 82. Freenome Description and Business Overview

Table 83. Freenome AI In Vitro Diagnostic Products, Services and Solutions

Table 84. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Freenome (2019-2024)

Table 85. Freenome Recent Developments

Table 86. GE Healthcare Basic Information List

Table 87. GE Healthcare Description and Business Overview

Table 88. GE Healthcare AI In Vitro Diagnostic Products, Services and Solutions

Table 89. Revenue (US$ Million) in AI In Vitro Diagnostic Business of GE Healthcare (2019-2024)

Table 90. GE Healthcare Recent Developments

Table 91. Glooko Basic Information List

Table 92. Glooko Description and Business Overview

Table 93. Glooko AI In Vitro Diagnostic Products, Services and Solutions

Table 94. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Glooko (2019-2024)

Table 95. Glooko Recent Developments

Table 96. Adaptive Biotechnologies Basic Information List

Table 97. Adaptive Biotechnologies Description and Business Overview

Table 98. Adaptive Biotechnologies AI In Vitro Diagnostic Products, Services and Solutions

Table 99. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Adaptive Biotechnologies (2019-2024)

Table 100. Adaptive Biotechnologies Recent Developments

Table 101. Aidoc Basic Information List

Table 102. Aidoc Description and Business Overview

Table 103. Aidoc AI In Vitro Diagnostic Products, Services and Solutions

Table 104. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Aidoc (2019-2024)

Table 105. Aidoc Recent Developments

Table 106. Anumana Basic Information List

Table 107. Anumana Description and Business Overview

Table 108. Anumana AI In Vitro Diagnostic Products, Services and Solutions

Table 109. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Anumana (2019-2024)

Table 110. Anumana Recent Developments

Table 111. ARUP Laboratories Basic Information List

Table 112. ARUP Laboratories Description and Business Overview

Table 113. ARUP Laboratories AI In Vitro Diagnostic Products, Services and Solutions

Table 114. Revenue (US$ Million) in AI In Vitro Diagnostic Business of ARUP Laboratories (2019-2024)

Table 115. ARUP Laboratories Recent Developments

Table 116. K Health Basic Information List

Table 117. K Health Description and Business Overview

Table 118. K Health AI In Vitro Diagnostic Products, Services and Solutions

Table 119. Revenue (US$ Million) in AI In Vitro Diagnostic Business of K Health (2019-2024)

Table 120. K Health Recent Developments

Table 121. Lunit Basic Information List

Table 122. Lunit Description and Business Overview

Table 123. Lunit AI In Vitro Diagnostic Products, Services and Solutions

Table 124. Revenue (US$ Million) in AI In Vitro Diagnostic Business of Lunit (2019-2024)

Table 125. Lunit Recent Developments

Table 126. Key Raw Materials Lists

Table 127. Raw Materials Key Suppliers Lists

Table 128. AI In Vitro Diagnostic Downstream Customers

Table 129. AI In Vitro Diagnostic Distributors List

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

Table 133. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. AI In Vitro Diagnostic Product Picture

Figure 2. Global AI In Vitro Diagnostic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global AI In Vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 4. AI In Vitro Diagnostic Report Years Considered

Figure 5. Global AI In Vitro Diagnostic Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by AI In Vitro Diagnostic Revenue in 2023

Figure 7. AI In Vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Next-Generation Sequencing Technology Picture

Figure 9. PCR Technology Picture

Figure 10. Chemistry and IA Technology Picture

Figure 11. Pathology Technology Picture

Figure 12. Global AI In Vitro Diagnostic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global AI In Vitro Diagnostic Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Cancer Diagnostics

Figure 15. Product Picture of Infectious Disease Testing

Figure 16. Product Picture of Metabolic Testing

Figure 17. Product Picture of Cardiac Testing

Figure 18. Product Picture of Diabetes Testing

Figure 19. Global AI In Vitro Diagnostic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 20. Global AI In Vitro Diagnostic Sales Value Market Share by Application, 2023 & 2030

Figure 21. North America AI In Vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 22. North America AI In Vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 23. Europe AI In Vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 24. Europe AI In Vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 25. Asia Pacific AI In Vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 26. Asia Pacific AI In Vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 27. South America AI In Vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 28. South America AI In Vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 29. Middle East & Africa AI In Vitro Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 30. Middle East & Africa AI In Vitro Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 31. Key Countries/Regions AI In Vitro Diagnostic Sales Value (%), (2019-2030)

Figure 32. United States AI In Vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 33. United States AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 34. United States AI In Vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 35. Europe AI In Vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 36. Europe AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 37. Europe AI In Vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 38. China AI In Vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 39. China AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 40. China AI In Vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 41. Japan AI In Vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 42. Japan AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 43. Japan AI In Vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 44. South Korea AI In Vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 45. South Korea AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 46. South Korea AI In Vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 47. Southeast Asia AI In Vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 48. Southeast Asia AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 49. Southeast Asia AI In Vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 50. India AI In Vitro Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 51. India AI In Vitro Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 52. India AI In Vitro Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 53. AI In Vitro Diagnostic Industrial Chain

Figure 54. AI In Vitro Diagnostic Manufacturing Cost Structure

Figure 55. Channels of Distribution (Direct Sales, and Distribution)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-35W10545

Tue Dec 03 00:00:00 UTC 2024

Add to Cart

Global Diabetic Care Dressings Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-30Z18417

Tue Dec 03 00:00:00 UTC 2024

Add to Cart

Endoscopy Operative Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-29M10233

Tue Dec 03 00:00:00 UTC 2024

Add to Cart

Veterinary Computed Radiography(CR) System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-25B13599

Tue Dec 03 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

AI In Vitro Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: April 2024

Report Code: QYRE-Auto-21Z14658

AI In Vitro Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

AI In Vitro Diagnostic - Market

Report Scope

Scope of AI In Vitro Diagnostic - Market Report

Chapter Outline

FAQ for this report

Who are the main players in the AI In Vitro Diagnostic - Market report?

What are the Application segmentation covered in the AI In Vitro Diagnostic - Market report?

What are the Type segmentation covered in the AI In Vitro Diagnostic - Market report?

FEATURED COMPANIES

RELATED REPORTS